| UniProt ID | KCC1A_HUMAN | |
|---|---|---|
| UniProt AC | Q14012 | |
| Protein Name | Calcium/calmodulin-dependent protein kinase type 1 | |
| Gene Name | CAMK1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 370 | |
| Subcellular Localization | Cytoplasm. Nucleus. Predominantly cytoplasmic.. | |
| Protein Description | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) elevation, promotes dendritic growth in hippocampal neurons and is essential in synapses for full long-term potentiation (LTP) and ERK2-dependent translational activation. Downstream of NMDA receptors, promotes the formation of spines and synapses in hippocampal neurons by phosphorylating ARHGEF7/BETAPIX on 'Ser-694', which results in the enhancement of ARHGEF7 activity and activation of RAC1. Promotes neuronal differentiation and neurite outgrowth by activation and phosphorylation of MARK2 on 'Ser-91', 'Ser-92', 'Ser-93' and 'Ser-294'. Promotes nuclear export of HDAC5 and binding to 14-3-3 by phosphorylation of 'Ser-259' and 'Ser-498' in the regulation of muscle cell differentiation. Regulates NUMB-mediated endocytosis by phosphorylation of NUMB on 'Ser-276' and 'Ser-295'. Involved in the regulation of basal and estrogen-stimulated migration of medulloblastoma cells through ARHGEF7/BETAPIX phosphorylation (By similarity). Is required for proper activation of cyclin-D1/CDK4 complex during G1 progression in diploid fibroblasts. Plays a role in K(+) and ANG2-mediated regulation of the aldosterone synthase (CYP11B2) to produce aldosterone in the adrenal cortex. Phosphorylates EIF4G3/eIF4GII. In vitro phosphorylates CREB1, ATF1, CFTR, MYL9 and SYN1/synapsin I.. | |
| Protein Sequence | MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRHMRKLQLGTSQEGQGQTASHGELLTPVAGGPAAGCCCRDCCVEPGTELSPTLPHQL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Phosphorylation | AEDIRDIYDFRDVLG HHHHHHHHCHHHHHC | 17.20 | 21951684 | |
| 59 | Ubiquitination | AKEALEGKEGSMENE HHHHHCCCCCCCHHH | 49.91 | 23707388 | |
| 131 | Phosphorylation | QVLDAVKYLHDLGIV HHHHHHHHHHHCCCC | 11.58 | 18083107 | |
| 143 | Ubiquitination | GIVHRDLKPENLLYY CCCCCCCCHHHCEEE | 55.35 | - | |
| 149 | Phosphorylation | LKPENLLYYSLDEDS CCHHHCEEEECCCCC | 8.32 | 27642862 | |
| 173 | Phosphorylation | SKMEDPGSVLSTACG CCCCCCCCHHHHCCC | 25.85 | 27486199 | |
| 176 | Phosphorylation | EDPGSVLSTACGTPG CCCCCHHHHCCCCCC | 16.29 | 23401153 | |
| 177 | Phosphorylation | DPGSVLSTACGTPGY CCCCHHHHCCCCCCC | 23.08 | 21712546 | |
| 181 | Phosphorylation | VLSTACGTPGYVAPE HHHHCCCCCCCCCHH | 17.27 | 28857561 | |
| 184 | Phosphorylation | TACGTPGYVAPEVLA HCCCCCCCCCHHHHC | 8.47 | 27486199 | |
| 235 | Phosphorylation | EQILKAEYEFDSPYW HHHHHHHCCCCCCCC | 27.10 | 21951684 | |
| 301 | Phosphorylation | IKKNFAKSKWKQAFN HHHHHHHHHHHHHHH | 40.08 | 23285258 | |
| 310 | Phosphorylation | WKQAFNATAVVRHMR HHHHHHHHHHHHHHH | 22.53 | 28857561 | |
| 323 | Phosphorylation | MRKLQLGTSQEGQGQ HHHCCCCCCCCCCCC | 35.51 | 28450419 | |
| 324 | Phosphorylation | RKLQLGTSQEGQGQT HHCCCCCCCCCCCCC | 25.16 | 26657352 | |
| 331 | Phosphorylation | SQEGQGQTASHGELL CCCCCCCCCCCCEEE | 36.63 | 28450419 | |
| 333 | Phosphorylation | EGQGQTASHGELLTP CCCCCCCCCCEEECC | 35.10 | 28450419 | |
| 339 | Phosphorylation | ASHGELLTPVAGGPA CCCCEEECCCCCCCC | 28.48 | 28857561 | |
| 360 | Phosphorylation | DCCVEPGTELSPTLP HCCCCCCCCCCCCCC | 44.46 | 29396449 | |
| 363 | Phosphorylation | VEPGTELSPTLPHQL CCCCCCCCCCCCCCC | 15.03 | 23707388 | |
| 365 | Phosphorylation | PGTELSPTLPHQL-- CCCCCCCCCCCCC-- | 49.93 | 28450419 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 177 | T | Phosphorylation | Kinase | KCC1A | Q14012 | PhosphoELM |
| 177 | T | Phosphorylation | Kinase | CAMKK1 | Q8N5S9 | Uniprot |
| 177 | T | Phosphorylation | Kinase | CAMKK2 | Q96RR4 | Uniprot |
| 177 | T | Phosphorylation | Kinase | CAMK1-FAMILY | - | GPS |
| 177 | T | Phosphorylation | Kinase | CAM-KI_GROUP | - | PhosphoELM |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXL12 | Q9NXK8 | PMID:22199232 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 177 | T | Phosphorylation |
| 7641687 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCC1A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KKCC2_HUMAN | CAMKK2 | physical | 10187789 | |
| GCM1_HUMAN | GCM1 | physical | 21791615 | |
| A4_HUMAN | APP | physical | 21832049 | |
| CDN1B_HUMAN | CDKN1B | physical | 23707388 | |
| CCND1_HUMAN | CCND1 | physical | 23707388 | |
| CDK4_HUMAN | CDK4 | physical | 23707388 | |
| MARK2_HUMAN | MARK2 | physical | 17442826 | |
| BLK_HUMAN | BLK | physical | 26186194 | |
| PPME1_HUMAN | PPME1 | physical | 24841198 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Human calcium-calmodulin dependent protein kinase I: cDNA cloning,domain structure and activation by phosphorylation at threonine-177 bycalcium-calmodulin dependent protein kinase I kinase."; Haribabu B., Hook S.S., Selbert M.A., Goldstein E.G., Tomhave E.D.,Edelman A.M., Snyderman R., Means A.R.; EMBO J. 14:3679-3686(1995). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-177, MUTAGENESIS OFLYS-49 AND THR-177, AND ENZYME REGULATION. | |